Navigation Links
DURECT Corporation Announces Fourth Quarter and Year End 2010 Financial Results
Date:3/2/2011

ndpoints, our potential failure to maintain our collaborative agreements with third parties or consummate new collaborations and DURECT's (and that of its third party collaborators where applicable) difficulty or failure to obtain approvals from regulatory agencies with respect to its development activities and products, or ability to design, enroll, conduct and complete clinical trials, complete the design, development, and manufacturing process development of the referenced product candidates, manufacture and commercialize the referenced product candidates, obtain marketplace acceptance of the referenced product candidates, avoid infringing patents held by other parties and secure and defend patents of our own, and manage and obtain capital to fund its growth, operations and expenses. Further information regarding these and other risks is included in DURECT's Form 10-Q on November 4, 2010 under the heading "Risk Factors."

DURECT CORPORATION STATEMENTS OF OPERATIONS DATA(in thousands, except per share amounts)(unaudited)Three months ended Year ended December 31, December 31, 201020092010 2009  (1)Collaborative research and development and other revenue

$  5,929$  2,802$  20,091$  12,347Product revenue, net

2,5672,07611,50012,113Total revenues

8,4964,87831,59124,460Operating expenses:Cost of revenues (2)

1,1778164,2755,311Research and development (2)

9,4479,26736,21434,801Selling, general and administrative (2)

4,0453,43214,93715,020Total operating expenses

14,66913,51555,42655,132Loss from operations

(6,173)(8,637)(23,835)(30,672)Other income (expense):Interest and other income

85853943420Interest and other expense

(1)(5)(6)(36)Net other income

85748937384Net loss

$ (5,316)$ (8,589)$ (22,898)$ (30,288)Net loss per share, basic and diluted

$   (0.06)$   (0.10)$
(0.26)$
(0.36)Shares used in computing basic and diluted net los
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. DURECTs Collaboration With Alpharma Clears HSR Review and Is Effective
2. DURECT Corporation Announces Third Quarter 2008 Financial Results
3. DURECT Corporation Invites You to Join its Third Quarter 2010 Earnings Conference Call
4. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
5. Pharmos Corporation Reports 2008 Second Quarter Results
6. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
7. Genaera Corporation Announces Second Quarter Financial Results
8. MannKind Corporation Reports Second Quarter Financial Results
9. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
10. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
11. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015 RXi Pharmaceuticals ... on discovering and developing innovative therapeutics, primarily in the ... of a public offering of 26 million units at ... for gross proceeds of approximately $10.4 million. Each unit ... a 13-month overallotment purchase right to purchase 0.50 of ...
(Date:5/28/2015)... -- GenVec, Inc. (Nasdaq: GNVC ) today announced that ... will present a company overview at the Jefferies 2015 ... June 4, 2015. The live and ... at the following link:  http://wsw.com/webcast/jeff88/gnvc .  This link ... visit www.genvec.com , click on "Investors and Media" ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 The Fertility ... our own Dr. Danielle Vitiello has taken on a ... role, Dr. Vitiello will provide guidance, leadership, oversight and ... to count Dr. Vitiello among our team of experienced ... and CEO, Joseph A. Hill, M.D. “Her expertise and ...
(Date:5/28/2015)... May 28, 2015 Whitehouse Laboratories is ... its long term partnership with PTI Inspection Systems. Whitehouse ... provide clients with custom-tailored method development and validation ... currently available. The agreement includes a more formal program ... across organizational lines. This enables a more effective team ...
Breaking Biology Technology:RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 3GenVec To Present At The Jefferies Healthcare Conference 2Danielle Vitiello, MD of Fertility Centers of New England, Named New Medical Director 2Whitehouse Labs Renews & Enhances Partnership with PTI Inspection Systems 2Whitehouse Labs Renews & Enhances Partnership with PTI Inspection Systems 3
... Interleukin Genetics,Inc. (AMEX: ILI ), announced today ... Wednesday, May 14, 2008 at 4:30 p.m. ET to ... an update on recent,corporate developments., To access the ... webcast will be available on the Investors,section of the ...
... Patent Encompassing Tobramycin Inhalation Powder and Other ... Aminoglycoside Antibiotics Issued to Nektar, SAN ... ) today announced that the U.S. Patent and Trademark ... methods for,creating and delivering Tobramycin Inhalation Powder (TIP) and ...
... Dermagraft presence within government channels, WEST ... Advanced,BioHealing, Inc. (ABH) and Regenesis Biomedical, ... promotion of Dermagraft(R) within the United,States (US) ... agreement,Regenesis will provide its specialized sales force ...
Cached Biology Technology:Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results 2Nektar Receives Patent Covering Pulmonary Targeted Antibiotics 2Nektar Receives Patent Covering Pulmonary Targeted Antibiotics 3Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 2Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 3
(Date:4/27/2015)... 2015  For more than four decades, AUVSI,s ... the premier worldwide event for the unmanned land, sea, ... event for any local, national, or trade news organization ... markets and current applications of unmanned technologies. The conference ... $48 billion industry, and how it will soon impact ...
(Date:4/21/2015)... 2015 High crime rate, ... boosting access control systems market in Saudi ... recently published report by TechSci Research " Saudi Arabia Access ... control systems market in Saudi Arabia ... access control systems market in the Kingdom is growing ...
(Date:4/17/2015)... 2015 Increasing adoption ... advancement to drive biometric systems market in ... According to a recently released TechSci ... ", biometric systems market in Saudi ... at CAGR of over 22% through 2020. The ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... at borders. Mexico, the U.S., and Canada share the ... problems. In an effort to promote active communication among ... and the Institute of Geology of the National Autonomous ... are hosting the 108th meeting of GSA,s Cordilleran Section ...
... includes a USC scientist has methodically demonstrated that a face,s ... are the key to recognizing a person. Their ... faces "holistically," appears this month in Psychological Science . ... brain functions, these results may help scientists understand rare facial ...
... describes how bacteria use a previously unknown means to defeat ... a common "housekeeping" enzyme in a way that enables the ... appears in the Proceedings of the National Academy ... warfare with one another, and many antibiotics used in medicine ...
Cached Biology News:Geological Society of America Cordilleran section meets in the heart of Mexico 2Geological Society of America Cordilleran section meets in the heart of Mexico 3Geological Society of America Cordilleran section meets in the heart of Mexico 4New research about facial recognition turns common wisdom on its head 2Team discovers how bacteria resist a 'Trojan horse' antibiotic 2
... venom Description: Phosphodiesterase I (venom ... studying nucleic acid structure and ... 5'-mononucleotides from 3'-hydroxy-terminated ribo-oligonucleotides and ... cleaves ADP-ribosylated proteins at the ...
... IITC Life Science Rotarods are used to assess ... or fatigue resistance on mice and rats using ... Extremely user friendly; the animals are placed on ... drops onto the individual sensing platforms below, its ...
... DNase I Amplification Grade ... DNA to oligodeoxyribonucleotides. The ... units/mg. DNAse I Amplification ... and tested for absence ...
... DNase I, ds Qualified is a special ... be used for double stranded cleavage of DNA ... of Mg2+, the enzyme makes double strand breaks ... of the resulting fragments can be controlled by ...
Biology Products: